Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Moxifloxacin prophylaxis is associated with higher bacteraemia and adverse event rates than levofloxacin prophylaxis

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      von Baum H, Sigge A, Bommer M, Kern WV, Marre R, Döhner H, Kern P, Reuter S.Moxifloxacin prophylaxis in neutropenic patients. Journal of Antimicrobial Chemotherapy 58: 891-894, No. 4, Oct 2006

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Moxifloxacin prophylaxis is associated with higher bacteraemia and adverse event rates than levofloxacin prophylaxis. React. Wkly. 1130, 5 (2006). https://doi.org/10.2165/00128415-200611300-00011

    Download citation

    Keywords

    • Public Health
    • Adverse Event
    • Survival Rate
    • Neutropenia
    • Event Rate